Browsing by Author "Sushmita Chowdhury"

Now showing 1 - 1 of 1

Management of interstitial lung diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP)
(Wolters Kluwer Medknow Publications, 2020) Sheetu Singh; Bharat Sharma; Mohan Bairwa; Dipti Gothi; Unnati Desai; Jyotsna Joshi; Deepak Talwar; Abhijeet Singh; Raja Dhar; Ambika Sharma; Bineet Ahluwalia; Daya Mangal; Nirmal Jain; Khushboo Pilania; Vijay Hadda; Parvaiz Koul; Shanti Luhadia; Rajesh Swarnkar; Shailender Gaur; Aloke Ghoshal; Amita Nene; Arpita Jindal; Bhavin Jankharia; Chetambath Ravindran; Dhruv Choudhary; Digambar Behera; D. Christopher; Gopi Khilnani; Jai Samaria; Harpreet Singh; Krishna Gupta; Manju Pilania; Manohar Gupta; Narayan Misra; Nishtha Singh; Prahlad Gupta; Prashant Chhajed; Raj Kumar; Rajesh Chawla; Rajendra Jenaw; Rakesh Chawla; Randeep Guleria; Ritesh Agarwal; R. Narsimhan; Sandeep Katiyar; Sanjeev Mehta; Sahajal Dhooria; Sushmita Chowdhury; Surinder Jindal; Subodh Katiyar; Sudhir Chaudhri; Neeraj Gupta; Sunita Singh; Surya Kant; Zarir Udwadia; Virendra Singh; Ganesh Raghu
Background: Interstitial lung disease (ILD) is a complex and heterogeneous group of acute and chronic lung diseases of several known and unknown causes. While clinical practice guidelines (CPG) for idiopathic pulmonary fibrosis (IPF) have been recently updated, CPG for ILD other than IPF are needed. Methods: A working group of multidisciplinary clinicians familiar with clinical management of ILD (pulmonologists, radiologist, pathologist, and rheumatologist) and three epidemiologists selected by the leaderships of Indian Chest Society and National College of Chest Physicians, India, posed questions to address the clinically relevant situation. A systematic search was performed on PubMed, Embase, and Cochrane databases. A modified GRADE approach was used to grade the evidence. The working group discussed the evidence and reached a consensus of opinions for each question following face-to-face discussions. Results: Statements have been made for each specific question and the grade of evidence has been provided after performing a systematic review of literature. For most of the questions addressed, the available evidence was insufficient and of low to very low quality. The consensus of the opinions of the working group has been presented as statements for the questions and not as an evidence-based CPG for the management of ILD. Conclusion: This document provides the guidelines made by consensus of opinions among experts following discussion of systematic review of evidence pertaining to the specific questions for management of ILD other than IPF. It is hoped that this document will help the clinician understand the accumulated evidence and help better management of idiopathic and nonidiopathic interstitial pneumonias. © 2020 Wolters Kluwer Medknow Publications. All rights reserved.